Your weekly roundup of the latest news from Drug Topics®.
Artificial intelligence can be a key tool for streamlining pharmacy workflows.
Three new bills signed Monday will require PBMs to use prescription drug rebates to lower premiums and out-of-pocket costs for consumers and prevent the practice of spread pricing.
Researchers encourage physicians to personalize care plans to ensure that more patients adhere to their inhalers.
Underlying HIV infection was independently associated with neurocognitive long COVID symptoms.
A study examined STI rates following doxycycline post-exposure prophylaxis to see if it could reduce infection rates.
How Mark Cuban Cost Plus Drug Company Is Approaching Drug Pricing Transparency
October 14th 2024Erin Albert, vice president of pharmacy relations and chief privacy officer at Mark Cuban Cost Plus Drug Company, PBC, discussed drug pricing and what her company is doing to revolutionize transparency.